cas12051-sup-0001-FigureS1.tiffTIFF image74KFig. S1. Chemical structure of withaferin A.
cas12051-sup-0002-FigureS2.tiffTIFF image148KFig. S2. Withaferin A blocked tumor promoter UVC-induced skin cell transformation.
cas12051-sup-0003-FigureS3.tiffTIFF image290KFig. S3. (a) Withaferin A suppressed TPA-induced cell proliferation during early skin carcinogenesis. (b,c) Withaferin A did not cause apoptosis.
cas12051-sup-0004-FigureS4.tiffTIFF image171KFig. S4. mRNA level of IDH1 and IDH2.
cas12051-sup-0005-FigureS5.tiffTIFF image180KFig. S5. Withaferin A did not affect tumor promoter TPA-induced phosphorylation of ERK, JNK and AKT.
cas12051-sup-0006-FigureS6.tiffTIFF image157KFig. S6. Withaferin A did not affect GDH activity in JB6 cells.
cas12051-sup-0007-FigureS7.tiffTIFF image118KFig. S7. Withaferin A did not alter IDH2 protein expression in JB6 cells.
cas12051-sup-0008-DataS1.docWord document30KData S1. Materials and Methods.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.